Document Actions

You are here: Home › Faculty › Professors › Seufert

Seufert

Prof. Dr.
Jochen Seufert, M.D., Ph.D., FRCPE

Department of Internal Medicine II
Tel.: Phone: 0049-761-270-34200

www.uniklinik-freiburg.de/endokrinologie.html

CV

  • 1983-1989 Medical School, Universities of  Würzburg, Germany  and Innsbruck, Austria
  • 1990-1995 Intern and Fellow in Endocrinology and Diabetology, Gastroenterology, Medizinische Poliklinik, University of Würzburg, Germany
  • 1995-1998 Research Fellowship and Instructor, Harvard Medical School, Massachusetts General Hospital, Joslin Diabetes Center, Boston, USA
  • 1998-2006 Fellow in Endocrinology and Diabetology, Gastroenterology Habilitation, Consultant and Head of Division of Endocrinology, Metabolism and Molecular Medicine, Medizinische Poliklinik, University of Würzburg, Germany
  • Since 2006 Full Professor (W3) of Internal Medicine, Head of the Division of Endocrinology and Diabetology, Medical Center – University of Freiburg

Focus of research

  • Molecular and cellular biology of the endocrine pancreas
  • Regenerative strategies for treatment of diabetes mellitus, stem cell therapy, pancreatic islet transplantation
  • Clinical trial unit, trials in diabetes mellitus, gestational diabetes, osteoporosis, endocrine disorders

Selected publications

  • Perakakis N, Triantafyllou GA, Fernández-Real JM, Huh JY, Park KH, Seufert J, Mantzoros CS. Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol. 2017; 13(6):324-337.
  • Marso SP, Bain SC, Consoli A, Eliaschewitz FG, Jódar E, Leiter LA, Lingvay I, Rosenstock J, Seufert J, Warren ML et al. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med. 2016; 375(19):1834-1844.
  • Laubner K, Kieffer TJ, Lam NT, Niu X, Jakob F, Seufert J. Inhibition of preproinsulin gene expression by leptin induction of suppressor of cytokine signaling 3 in pancreatic beta-cells. Diabetes. 2005; 54(12):3410-7.
  • Seufert J, Ebert K, Müller J, Eulert J, Hendrich C, Werner E, Schuüze N, Schulz G, Kenn W, Richtmann H et al. Octreotide therapy for tumor-induced osteomalacia. N Engl J Med. 2001; 345(26):1883-8.
  • Seufert J, Weir GC, Habener JF. Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus. J Clin Invest. 1998; 101(11):2528-39.